Related Experiment Videos
Apolipoprotein A-I-binding protein from human term placenta. Purification and partial characterization.
FEBS Letters
|May 4, 1987
Summary
Researchers isolated a placental protein that binds to apolipoprotein A-I (apoA-I), the main component of high-density lipoprotein (HDL). This discovery offers new insights into HDL metabolism and potential therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Human Physiology
Background:
- High-density lipoprotein (HDL) plays a crucial role in reverse cholesterol transport.
- Apolipoprotein A-I (apoA-I) is the primary structural and functional protein of HDL.
- Understanding HDL-protein interactions is vital for metabolic research.
Purpose of the Study:
- To isolate and characterize a novel protein from human placenta that interacts with apoA-I.
- To elucidate the binding properties and specificity of this isolated protein.
Main Methods:
- Protein isolation from human placenta.
- Ligand blotting following SDS-gel electrophoresis (reducing and non-reducing conditions).
- Enzyme-linked immunosorbent assay (ELISA) to determine binding specificity.
Main Results:
- A 120 kDa protein from human placenta was isolated that binds apoA-I.
- Under reducing conditions, the protein dissociated into ~50 kDa and ~30 kDa subunits, which did not bind apoA-I.
- The isolated protein specifically bound apoA-I in both delipidated and HDL-associated forms.
- Other apolipoproteins (ApoA-II, apoE) and low-density lipoprotein (LDL) did not compete for apoA-I binding.
Conclusions:
- A novel apoA-I binding protein has been identified in human placenta.
- This protein exhibits specific binding to apoA-I, suggesting a potential role in HDL metabolism or clearance.
- The protein's interaction with apoA-I warrants further investigation into its physiological significance.